BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Colorectal Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: This is a single arm study of de-escalating arms to determine the MTD and then expand the trial.It is not randomized.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03791398
- Collaborators
- Brown University
- Rhode Island Hospital
- Bristol-Myers Squibb
- Oncoceutics, Inc.
- Investigators
- Not Provided